X
IOVA icon

Xponance’s Iovance Biotherapeutics IOVA Stock Holding History

Xponance’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Buy
38,129
+7,610
+25% +$28.9K ﹤0.01% 1652
2026
Q1 		$107K Buy
30,519
+6,231
+26% +$19.9K ﹤0.01% 1567
2025
Q4 		$66.3K Buy
24,288
+3,950
+19% +$9.14K ﹤0.01% 1502
2025
Q3 		$44.1K Buy
20,338
+398
+2% +$940 ﹤0.01% 1495
2025
Q2 		$34.3K Sell
19,940
-787
-4% -$1.96K ﹤0.01% 1476
2025
Q1 		$69K Buy
20,727
+1,120
+6% +$5.78K ﹤0.01% 1377
2024
Q4 		$145K Buy
19,607
+3,066
+19% +$28.4K ﹤0.01% 1326
2024
Q3 		$155K Buy
16,541
+262
+2% +$2.48K ﹤0.01% 1275
2024
Q2 		$131K Buy
16,279
+1,873
+13% +$20.1K ﹤0.01% 1226
2024
Q1 		$213K Buy
14,406
+557
+4% +$6.48K ﹤0.01% 1170
2023
Q4 		$113K Buy
13,849
+390
+3% +$2.04K ﹤0.01% 1203
2023
Q3 		$61.2K Buy
13,459
+1,215
+10% +$7.93K ﹤0.01% 1192
2023
Q2 		$86.2K Buy
+12,244
New +$87.6K ﹤0.01% 1202
2021
Q2 		– Sell
-14,531
Closed -$460K – 1256
2021
Q1 		$460K Buy
14,531
+195
+1% +$8.08K 0.01% 814
2020
Q4 		$665K Sell
14,336
-61
-0.4% -$2.42K 0.01% 620
2020
Q3 		$474K Buy
14,397
+72
+0.5% +$2.21K 0.01% 666
2020
Q2 		$393K Buy
+14,325
New +$471K 0.01% 717

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Xponance's IOVA Position: Q2 2026 in Review

Xponance increased its Iovance Biotherapeutics (IOVA) stake by 25% in Q2 2026, buying an estimated $28.9K and bringing the position to 38,129 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #1652.

Xponance first reported a position in IOVA in Q2 2020 and has held it in 17 quarters since. The position peaked at $665K in Q4 2020. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Xponance held 38,129 shares of Iovance Biotherapeutics worth $159K as of Q2 2026.
  • Xponance bought 7,610 Iovance Biotherapeutics shares in Q2 2026, an estimated $28.9K.
  • Iovance Biotherapeutics made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1652 holding.
  • Xponance first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 17 quarters since.
  • Xponance's Iovance Biotherapeutics position peaked at $665K in Q4 2020.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.